Ensign Peak Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $526K | Sell |
17,793
-4,150
| -19% | -$123K | ﹤0.01% | 1539 |
|
|
2025
Q1 | $655K | Hold |
21,943
| – | – | ﹤0.01% | 1459 |
|
|
2024
Q4 | $629K | Hold |
21,943
| – | – | ﹤0.01% | 1535 |
|
|
2024
Q3 | $848K | Hold |
21,943
| – | – | ﹤0.01% | 1418 |
|
|
2024
Q2 | $707K | Hold |
21,943
| – | – | ﹤0.01% | 1483 |
|
|
2024
Q1 | $852K | Sell |
21,943
-1,107
| -5% | -$43K | ﹤0.01% | 1421 |
|
|
2023
Q4 | $709K | Hold |
23,050
| – | – | ﹤0.01% | 1558 |
|
|
2023
Q3 | $515K | Hold |
23,050
| – | – | ﹤0.01% | 1581 |
|
|
2023
Q2 | $495K | Hold |
23,050
| – | – | ﹤0.01% | 1634 |
|
|
2023
Q1 | $553K | Hold |
23,050
| – | – | ﹤0.01% | 1619 |
|
|
2022
Q4 | $535K | Buy |
23,050
+10,500
| +84% | +$244K | ﹤0.01% | 1602 |
|
|
2022
Q3 | $201K | Hold |
12,550
| – | – | ﹤0.01% | 1874 |
|
|
2022
Q2 | $222K | Hold |
12,550
| – | – | ﹤0.01% | 1761 |
|
|
2022
Q1 | $256K | Hold |
12,550
| – | – | ﹤0.01% | 1808 |
|
|
2021
Q4 | $234K | Sell |
12,550
-250
| -2% | -$4.66K | ﹤0.01% | 1886 |
|
|
2021
Q3 | $253K | Buy |
12,800
+5,300
| +71% | +$105K | ﹤0.01% | 1723 |
|
|
2021
Q2 | $177K | Buy |
7,500
+3,200
| +74% | +$75.5K | ﹤0.01% | 1733 |
|
|
2021
Q1 | $102K | Buy |
+4,300
| New | +$102K | ﹤0.01% | 1772 |
|